Monitoring the epidemic situation of tuberculosis in pri-
sons is of great importance in the Russian and internation-
al system of monitoring tuberculosis.
Objective of the
study
: to monitor the epidemic situation of tuberculosis
in Russian prisons. Methods. We used information from
official statistics. Extensive and intensive indicators were
calculated, regression analysis was used.
Results.
The in-
dicator “The proportion of people diagnosed with active
tuberculosis diagnosed for the first time in their lives in
penitentiary institutions in the total number of patients di-
agnosed with active tuberculosis for the first time in their
lives” is being successfully met. In 2019 it was 7.3% with a
target of 7.8%. The notification rate of new cases of tuber-
culosis is declining at a faster rate in correctional facilities
(to 465.0 per 100,000) and at a lower rate in pre-trial de-
tention centers (to 1251.0 per 100,000). The decline in the
notification rate of new cases of tuberculosis in pre-trial de-
tention centers may slow due to COVID-19. There is a fur-
ther decrease in the prevalence of tuberculosis (to 2,677.3
per 100,000) and TB mortality (to 7.0 per 100,000). The inci-
dence of TB/HIV among people living with HIV decreased
to 2506.0 per 100,000, while ART coverage increased to
59.5%. A strong inverse correlation was found between
the incidence of tuberculosis in people living with HIV and
their coverage of ART (r=-0.99). The prevalence of MDR-TB
has not changed over the past 3 years, amounting to 684.0
per 100,000 in 2019 with an increase in primary MDR to
32.8%.
Conclusion:
the TB epidemic situation continues
to improve, mainly in correctional facilities, less in pre-trial
detention centers. The improvement in the epidemic situa-
tion of tuberculosis with HIV infection is associated with an
increase in the coverage of people living with HIV with ART.
Two multidirectional processes ensure the lack of MDR-TB
dynamics: a decrease in the incidence of tuberculosis, on
the one hand, and an increase in primary multidrug resis-
tance of MBT, on the other.